MYRIAD GENETICS INC

By person

44 insiders · 135 transactions

5.5×

Samraat S. Raha holds 5.5 times base salary in stock. $4.76M of shares against $856.90K in salary for 2025.

Salary from the company's own proxy. The shares are what Samraat S. Raha last reported holding, valued at $4.46, the price Common Stock was last bought or sold at on the open market here, on 8 Jun 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

LANCHBURY JERRY S

See Remarks

—

$24.83M (34) scheduled

−$24.83M

264,324

0.2763%

$1.18M

+135.3%

Capone Mark Christopher

President & C.E.O.

—

$12.73M (7) scheduled

−$12.73M

522,216

0.5460%

$2.33M

+141.0%

MARSH RICHARD M

E.V.P., General Counsel

—

$9.15M (7) scheduled

−$9.15M

144,174

0.1507%

$642.47K

+30.9%

DIAZ PAUL J

President and CEO

—

$6.47M (5)

−$6.47M

891,844

0.9324%

$3.97M

—

LANGER DENNIS

Director

—

$4.53M (10) scheduled

−$4.53M

106,802

0.1117%

$475.93K

+510.3%

Hart Jayne B.

See Remarks

—

$4.28M (7) scheduled

−$4.28M

172,561

0.1804%

$768.97K

+75.6%

King Gary A.

Exec. VP International Ops

—

$4.09M (6) scheduled

−$4.09M

148,397

0.1551%

$661.29K

+34.3%

Riggsbee Richard Bryan

Chief Financial Officer

—

$3.45M (8)

−$3.45M

291,812

0.3051%

$1.30M

+315.3%

HENDERSON JOHN T

Director

$276.15K (5)

$2.17M (6) scheduled

−$1.89M

78,090

0.0816%

$347.98K

+258.2%

GILBERT WALTER PHD

Director

$150.00K (1)

$1.44M (3) scheduled

−$1.29M

54,150

0.0566%

$241.30K

+333.2%

Reitan Colleen F

Director

—

$1.29M (1) scheduled

−$1.29M

152,030

0.1589%

$677.48K

—

Lambert Nicole

Chief Operating Officer

—

$1.13M (8)

−$1.13M

223,993

0.2342%

$998.16K

+752.6%

Phanstiel S. Louise

Director

$744.06K (4)

$1.68M (1) scheduled

−$933.68K

362,652

0.3791%

$1.62M

+26,160%

SPIEGELMAN DANIEL K

Director

—

$792.26K (6)

−$792.26K

32,917

0.0344%

$146.68K

—

Tobin Bernard

President Crescendo BioScience

—

$468.48K (1)

−$468.48K

160,636

0.1679%

$715.83K

+28.4%

Ford Alexander

Chief Operating Officer

—

$352.72K (3)

−$352.72K

169,040

0.1767%

$753.28K

+394.9%

Ancona Margaret

EVP, Strategy & Transformation

—

$320.99K (1)

−$320.99K

127,726

0.1335%

$569.17K

—

Parkinson Paul

Fmr EVP Strategy & Innovation

—

$295.60K (1)

−$295.60K

87,407

0.0914%

$389.50K

+13.8%

Kumar Rashmi

Director

—

$276.92K (2) scheduled

−$276.92K

171,889

0.1797%

$765.97K

—

Dreismann Heinrich

Director

—

$270.52K (1)

−$270.52K

231,145

0.2417%

$1.03M

+176.7%

DREISMANN HEINRICH

Director

—

$201.00K (1)

−$201.00K

83,527

0.0873%

$372.21K

+377.3%

Raha Samraat S.

President and CEO

$199.84K (1)

—

+$199.84K

1,068,083

1.12%

$4.76M

—

Newcomer Lee Nisley

Director

—

$156.86K (1)

−$156.86K

191,842

0.2006%

$854.89K

—

McDade Ralph L

President Myriad RBM, Inc.

—

$61.23K (1)

−$61.23K

142,095

0.1486%

$633.20K

+63.5%

Muzzey Dale

Chief Scientific Officer

—

$54.96K (1)

−$54.96K

326,310

0.3412%

$1.45M

+798.9%

Bisaro Paul

Director

$27.64K (1)

—

+$27.64K

157,142

0.1643%

$700.26K

—

Verratti Mark

Chief Operating Officer

—

629,646

0.6583%

$2.81M

+6,196%

Donnelly Brian J

Chief Commercial Officer

—

573,363

0.5994%

$2.56M

—

Sikri Vishal

EVP, Commercial

—

351,224

0.3672%

$1.57M

+275.7%

Fox Jennifer Lynne

Chief Legal Officer

—

305,964

0.3199%

$1.36M

—

Wheeler Benjamin Richard

Chief Financial Officer

—

289,748

0.3029%

$1.29M

+722.9%

Solaiman Shereen

Chief People Officer

—

267,801

0.2800%

$1.19M

—

Jampa Raj

Chief Technology Officer

—

251,889

0.2633%

$1.12M

—

Leffler Scott J.

Chief Financial Officer

—

218,393

0.2283%

$973.20K

+26,862%

Skovronsky Daniel

Director

—

195,507

0.2044%

$871.22K

—

Haas Kevin Richard

Chief Technology Officer

—

180,022

0.1882%

$802.21K

+454.9%

Jackson Benjamin

Former E.V.P., General Counsel

—

107,029

0.1119%

$476.94K

+506.4%

Davis Mark Steven

Director

—

106,665

0.1115%

$475.32K

—

Wong Pamela

Chief Legal Officer

—

65,002

0.0680%

$289.66K

—

BEST LAWRENCE C

Director

—

60,790

0.0636%

$270.89K

+247.4%

Santa Eric

Former Chief Growth Officer

—

56,734

0.0593%

$252.82K

—

Wenstrup Richard

Chief Medical Officer

—

50,207

0.0525%

$223.73K

−1.8%

Munk Natalie

Chief Accounting Officer

—

45,167

0.0472%

$201.27K

+77.8%

Sanders Walter Lloyd

President Myriad Oncology

—

36,195

0.0378%

$161.29K

−9.4%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Hart Jayne B.

28 Feb 2022

Chief People Officer

Sold after exercise

3,500

$25.00

$87.50K

Hart Jayne B.

28 Feb 2022

Chief People Officer

Sold after exercise

7,000

$25.00

$175.00K

Hart Jayne B.

17 Sep 2021

Chief People Officer

Sold after exercise

2,966

$33.72

$100.01K

Hart Jayne B.

17 Sep 2021

Chief People Officer

Sold after exercise

64,480

$33.72

$2.17M

LANCHBURY JERRY S

24 Aug 2021

Chief Scientific Officer

Sold after exercise

30,000

$35.57

$1.07M

LANCHBURY JERRY S

23 Aug 2021

Chief Scientific Officer

Sold after exercise

40,000

$35.07

$1.40M

LANCHBURY JERRY S

23 Aug 2021

Chief Scientific Officer

Sold after exercise

10,000

$35.57

$355.70K

Phanstiel S. Louise

5 Aug 2021

Director

Sold after exercise

47,881

$35.04

$1.68M

LANCHBURY JERRY S

5 Aug 2021

Chief Scientific Officer

Sold after exercise

28,225

$35.57

$1.00M

LANCHBURY JERRY S

4 Aug 2021

Chief Scientific Officer

Sold after exercise

11,775

$35.57

$418.86K

LANCHBURY JERRY S

4 Aug 2021

Chief Scientific Officer

Sold after exercise

38,225

$35.24

$1.35M

LANGER DENNIS

3 Aug 2021

Director

Sold after exercise

30,000

$34.75

$1.04M

LANCHBURY JERRY S

3 Aug 2021

Chief Scientific Officer

Sold after exercise

4,170

$34.00

$141.78K

LANCHBURY JERRY S

3 Aug 2021

Chief Scientific Officer

Sold after exercise

27,830

$34.00

$946.22K

LANCHBURY JERRY S

3 Aug 2021

Chief Scientific Officer

Sold after exercise

1,775

$35.07

$62.25K

LANCHBURY JERRY S

3 Aug 2021

Chief Scientific Officer

Sold after exercise

16,225

$33.99

$551.49K

LANCHBURY JERRY S

13 Jul 2021

Chief Scientific Officer

Sold after exercise

40,000

$33.74

$1.35M

LANCHBURY JERRY S

13 Jul 2021

Chief Scientific Officer

Sold after exercise

3,295

$33.69

$111.01K

LANCHBURY JERRY S

12 Jul 2021

Chief Scientific Officer

Sold after exercise

13,295

$33.55

$446.08K

LANCHBURY JERRY S

12 Jul 2021

Chief Scientific Officer

Sold after exercise

36,705

$33.55

$1.23M

LANCHBURY JERRY S

9 Jul 2021

Chief Scientific Officer

Sold after exercise

17,692

$32.47

$574.46K

LANCHBURY JERRY S

9 Jul 2021

Chief Scientific Officer

Sold after exercise

5,603

$32.29

$180.92K

LANCHBURY JERRY S

9 Jul 2021

Chief Scientific Officer

Sold after exercise

26,705

$32.79

$875.66K

LANCHBURY JERRY S

7 Jul 2021

Chief Scientific Officer

Sold after exercise

1,884

$31.99

$60.27K

LANCHBURY JERRY S

7 Jul 2021

Chief Scientific Officer

Sold after exercise

30,424

$32.29

$982.39K

LANCHBURY JERRY S

28 Jun 2021

Chief Scientific Officer

Sold after exercise

948

$32.49

$30.80K

LANCHBURY JERRY S

28 Jun 2021

Chief Scientific Officer

Sold after exercise

1,891

$32.23

$60.95K

LANCHBURY JERRY S

28 Jun 2021

Chief Scientific Officer

Sold after exercise

3,973

$32.43

$128.85K

LANCHBURY JERRY S

25 Jun 2021

Chief Scientific Officer

Sold after exercise

33,372

$31.61

$1.06M

LANCHBURY JERRY S

25 Jun 2021

Chief Scientific Officer

Sold after exercise

28,640

$31.97

$915.62K

LANCHBURY JERRY S

25 Jun 2021

Chief Scientific Officer

Sold after exercise

21,360

$32.47

$693.56K

LANCHBURY JERRY S

4 May 2021

Chief Scientific Officer

Sold after exercise

19,360

$31.97

$618.95K

LANCHBURY JERRY S

27 Apr 2021

Chief Scientific Officer

Sold after exercise

40,000

$31.47

$1.26M

Hart Jayne B.

29 Mar 2021

Chief People Officer

Sold after exercise

8,034

$30.00

$241.02K

Hart Jayne B.

29 Mar 2021

Chief People Officer

Sold after exercise

21,966

$30.00

$658.98K

Hart Jayne B.

29 Mar 2021

Chief People Officer

Sold after exercise

28,000

$30.00

$840.00K

LANCHBURY JERRY S

16 Feb 2021

Chief Scientific Officer

Sold after exercise

5,555

$29.71

$165.06K

LANCHBURY JERRY S

16 Feb 2021

Chief Scientific Officer

Sold after exercise

74,445

$29.71

$2.21M

King Gary A.

1 Aug 2019

Exec. VP International Ops

Sold after exercise

20,000

$39.44

$788.81K

King Gary A.

1 Aug 2019

Exec. VP International Ops

Sold after exercise

10,000

$43.48

$434.82K

King Gary A.

1 Aug 2019

Exec. VP International Ops

Sold after exercise

30,000

$46.19

$1.39M

Capone Mark Christopher

1 Aug 2019

President & C.E.O.

Sold after exercise

3,862

$44.00

$169.93K

Capone Mark Christopher

1 Aug 2019

President & C.E.O.

Sold after exercise

58,138

$44.00

$2.56M

Capone Mark Christopher

1 Aug 2019

President & C.E.O.

Sold after exercise

4,328

$44.00

$190.43K

Capone Mark Christopher

1 Aug 2019

President & C.E.O.

Sold after exercise

70,672

$44.00

$3.11M

Capone Mark Christopher

11 Jul 2018

President & C.E.O.

Sold after exercise

2,346

$41.00

$96.19K

Capone Mark Christopher

11 Jul 2018

President & C.E.O.

Sold after exercise

77,654

$41.00

$3.18M

MARSH RICHARD M

11 Jul 2018

E.V.P., General Counsel

Sold after exercise

40,000

$42.02

$1.68M

MARSH RICHARD M

11 Jul 2018

E.V.P., General Counsel

Sold after exercise

30,672

$44.00

$1.35M

HENDERSON JOHN T

11 Jul 2018

Director

Sold after exercise

10,000

$40.17

$401.70K

HENDERSON JOHN T

11 Jul 2018

Director

Sold after exercise

10,000

$42.01

$420.09K

HENDERSON JOHN T

11 Jul 2018

Director

Sold after exercise

10,000

$44.00

$440.00K

LANCHBURY JERRY S

11 Jul 2018

Chief Scientific Officer

Sold after exercise

3,861

$43.34

$167.34K

LANCHBURY JERRY S

11 Jul 2018

Chief Scientific Officer

Sold after exercise

46,139

$43.34

$2.00M

MARSH RICHARD M

18 Jun 2018

E.V.P., General Counsel

Sold after exercise

33,000

$40.00

$1.32M

LANCHBURY JERRY S

18 Jun 2018

Chief Scientific Officer

Sold after exercise

2,346

$40.12

$94.12K

LANCHBURY JERRY S

18 Jun 2018

Chief Scientific Officer

Sold after exercise

57,654

$40.12

$2.31M

LANGER DENNIS

8 Jun 2018

Director

Sold after exercise

13,664

$39.35

$537.68K

LANGER DENNIS

7 Jun 2018

Director

Sold after exercise

3,096

$39.35

$121.83K

GILBERT WALTER PHD

6 Jun 2018

Director

Sold after exercise

1,189

$39.80

$47.32K

LANGER DENNIS

6 Jun 2018

Director

Sold after exercise

3,609

$39.37

$142.09K

LANGER DENNIS

5 Jun 2018

Director

Sold after exercise

1,227

$39.90

$48.96K

GILBERT WALTER PHD

5 Jun 2018

Director

Sold after exercise

28,811

$39.68

$1.14M

LANGER DENNIS

4 Jun 2018

Director

Sold after exercise

8,404

$39.90

$335.32K

LANGER DENNIS

4 Jun 2018

Director

Sold after exercise

10,000

$39.90

$399.00K

LANGER DENNIS

1 Jun 2018

Director

Sold after exercise

30,000

$38.90

$1.17M

LANGER DENNIS

30 May 2018

Director

Sold after exercise

10,000

$37.92

$379.25K

MARSH RICHARD M

30 May 2018

E.V.P., General Counsel

Sold after exercise

33,139

$38.00

$1.26M

Capone Mark Christopher

30 May 2018

President & C.E.O.

Sold after exercise

90,000

$38.00

$3.42M

LANGER DENNIS

21 May 2018

Director

Sold after exercise

10,000

$35.90

$359.00K

MARSH RICHARD M

22 Jan 2018

E.V.P., General Counsel

Sold after exercise

37,654

$40.25

$1.52M

King Gary A.

22 Jan 2018

Exec. VP International Ops

Sold after exercise

4,445

$39.03

$173.49K

King Gary A.

22 Jan 2018

Exec. VP International Ops

Sold after exercise

30,000

$39.77

$1.19M

King Gary A.

18 Jan 2018

Exec. VP International Ops

Sold after exercise

3,120

$38.12

$118.93K

MARSH RICHARD M

18 Jan 2018

E.V.P., General Counsel

Sold after exercise

40,000

$38.25

$1.53M

HENDERSON JOHN T

1 Sep 2017

Director

Sold after exercise

10,000

$30.30

$302.98K

HENDERSON JOHN T

1 Sep 2017

Director

Sold after exercise

10,000

$30.30

$303.00K

HENDERSON JOHN T

1 Sep 2017

Director

Sold after exercise

10,000

$30.31

$303.06K

Show all 135 transactions →

By person

Individual transactions

What was left out